Colossal Biosciences Funding & Investors

Austin, TX

Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics.

Total Amount Raised: $448,099,968

Colossal Biosciences Funding Rounds

Series C
$200,000,000
Jan 14, 2025
Series C Investors
Mark Walter
Thomas Tull
TWG Global
Series Unknown
$10,500,001
Nov 12, 2023
Series B
$162,599,950
Jan 30, 2023
Series B Investors
US Innovative Technology Fund
Bold Capital Partners
Breyer Capital
IQT (In-Q-Tel)
Animoca Brands
Jazz Venture Partners
WestRiver Group
Victor Vescovo
Animal Capital
PEAK6
Elias Montanari
Wave Digital Assets
Sahin Boydas
Robert Nelsen
Series A
$60,000,000
Mar 8, 2022
Series A Investors
At One Ventures
Thomas Tull
Builders VC
Charles Hoskinson
First Light Capital
Jazz Venture Partners
Animal Capital
Bold Capital Partners
Boost VC
Breyer Capital
Robert Nelsen
Draper Associates
Green Sands Equity
Paris Hilton
Animoca Brands
Untamed Planet
cFund
Milad Alucozai
11:11 Media
Seed
$15,000,000
May 5, 2021
Seed Investors
Thomas Tull
Tony Robbins
Capital Factory
Climate Capital
Jeff Wilke
Global Space Ventures
Winklevoss Capital
Draper Associates
Animal Capital
Liquid 2 Ventures
At One Ventures
First Light Capital
Jazz Venture Partners
Breyer Capital
Bold Capital Partners
Rayyan Islam
Kitty Hawk

Funding info provided by Diffbot.